Brean Capital analyst Jonathan Aschoff maintained a Buy rating on MEI Pharma (NASDAQ:MEIP) with a $16 price target, which represents a potential upside of …
In a research report sent to investors today, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on MEI Pharma (NASDAQ:MEIP) with a …
In a research report issued today, Roth Capital analyst Joseph Pantginis maintained a Buy rating on MEI Pharma (NASDAQ:MEIP) with a price target …
In a research report released yesterday, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on MEI Pharma (NASDAQ:MEIP) with a price target …
In a research note released yesterday, Brean Capital analyst Jonathan Aschoff reaffirmed a Buy rating on MEI Pharma (NASDAQ:MEIP) with a $16 price …
In a research report issued yesterday, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on MEI Pharma (NASDAQ:MEIP) with a price target …
